Área Sanitaria de Vigo
Área sanitaria
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicacións en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (5)
2024
-
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
Archivos de Bronconeumologia
2023
2017
-
Cross-cultural validation of lupus impact tracker in five European clinical practice settings
Rheumatology (United Kingdom), Vol. 56, Núm. 5, pp. 818-828
-
Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
Journal of the American Medical Directors Association, Vol. 18, Núm. 12, pp. 1097.e11-1097.e24
2016
-
Understanding remission in real-world lupus patients across five European countries
Lupus, Vol. 25, Núm. 5, pp. 505-512